Combining Locoregional and Systemic Therapy for Challenging HCC Cases

Target Audience
This educational activity is intended for interventional oncologyists physicians, nurses, and other members of the health care team who care for patients with hepatocellular carcinoma (HCC)

Program Overview
This activity focuses on challenges in the management of HCC using the latest clinical data supporting locoregional therapy, and on strategies for greater collaboration amongst the multidisciplinary teams in community vs academic settings.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Apply strategies for early and accurate diagnosis of HCC stages
Summarize MOA and clinical profiles of new and emerging immuno-oncology (IO) agents (mono and combo) for each stage of HCC
Analyze data on IO therapy with ADT procedures to identify appropriate patients
Describe the role of HCC care team members and explain techniques to increase communication and collaboration